Unpacking Schizophrenia: The Role of Clozapine and Shattering the Stigma

Schizophrenia is not a death sentence, says Robert S Laitman, MD, from Bronx Westchester Medical Group and SARDAA. In part 2 of this podcast series, Dr Laitman explains how his approach to treatment has helped the majority of his patients achieve meaningful recovery.

Discover more insight from your peers in our Behavioral Neurology Excellence Forum.

Robert S. Laitman, MD, is an internal medicine physician at Bronx Westchester Medical Group in New York. He is on the Board of Directors for the Schizophrenia and Related Disorders Alliance of America, and is also a board member of the National Alliance of Mental Illness - New York. Over the last 10 years, he has developed a practice taking care of people with psychotic disorders after his son, Daniel, received a diagnosis of schizophrenia in 2006.

Dr Laitman, his family, and his colleague authored the book, "Clozapine: Meaningful Recovery from Schizophrenia."

References:

1. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull. 1996;22(2):305-326. https://www.ncbi.nlm.nih.gov/pubmed/8782288
2. Kane JM, Schooler NO, Marcy P, et al. The RAISE early treatment program for first-episode psychosis: background, rationale, and study design. J Clin Psychiatry. 2015;76(3):240-246. doi:10.4088/JCP.14m09289
3. Dixon LB, Goldman HH, Bennett ME, et al. Implementing coordinated specialty care for early psychosis: The RAISE Connection Program. Psychiatr Serv. 2015; 66(7):691-8. doi:10.1176/appi.ps.201400281